Dasatinib

CAS No.:302962-49-8

Other Names:Dasatinib

Dasatinibis(CAS No.:302962-49-8) an orally potent inhibitor of oncogenic kinases that block the signal ofaccelerated cancer cell replication. In May 2009, the US Food and DrugAdministration (FDA) formally approved the sale of dasatinib. It has been usedfor the treatment of chronic myelocytic leukemia (CML), chronic ornon-resistant chronic myeloid leukemia, Philadelphia chromosome-positive acutelymphoblastic leukemia, and treatment regimens including imatinib mesylate.Treatment of patients with (Ph+ ALL) and solid tumors.

MF:C22H26ClN7O2S, C22H26ClN7O2S

Type:Auxiliaries and Other Medicinal Chemicals

Grade Standard:Food Grade, Medicine Grade

Purity: 99.0%min

Appearance:White powder

Grade:Medical Grade

CAS:302962-49-8

Sample:Free charge samples can be sent

Shelf life:3 years

Form:Powder

SupplyAbility

5500 Kilogram/Kilograms per Month

Packaging & Delivery

Drum, Plastic Container, Vacuum Packed

Port ; any port in China

Lead Time : 2 days After payment

ITEM	SPECIFICATION
Appearance:	White crystalline Powder
Assay:	≥99.0%
Heavy Metals	≤10ppm
Arsenic	≤1ppm
Lead	≤3ppm
Mercury	≤0.1ppm
Cadmium	≤1ppm
Total Plate Count	≤1000cfu/g
Yeast & Mold	≤100cfu/g
E.Coli	Negative
Salmonella	Negative

Products Recommended:

CAS No.: 231277-92-2

Send your message to us

(* We will reply your inquiry to this Email as soon as we see it.)

Other Products

PRODUCTS LIST

Office Address: No.41, Zhaiying South Street, Yuhua District, Shijiazhuang, Hebei Province.Chinaa
R&D and Plant Address: JingShi Cooperative Innovation Industrial Park,No.769 Taihang Street,High-tech Zone,Shijiazhuang
Tel: +86-311-67591193
Fax: +86-311-67591193
sales@dingminpharma.com

Product:
Name:	*
E-mail:	*
Tel:
Message:	*
Verification Code:	*

Erlotinib intermediates manufacturer

Dasatinib

CAS No.:302962-49-8

Other Names:Dasatinib

CAS No.: 231277-92-2